ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Ms. Zara - Chinese Medicine

Patient basic information Patient: Ms. Zara (Zara Walker) Nationality: Belgium Disease Diagnosis: Chinese Medical Oncology Diagnostic Hospital: H0C0 treatment program: Blood stem cell transplant + chemotherapy Hospitalization days: 25 days Treatment cost: about 342164 yuan Treatment effect: pain relief Description of the disease Ms. Zara is from Belgium and was diagnosed with Chinese Medical Oncology locally.

Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, escort and on-site services throughout the treatment process. The MDT Expert Group uses a comprehensive set of blood stem cell transplants + chemotherapy, and during the treatment the medical team closely monitors the patient's indicators and dynamic adjustment programs. After 25 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached hospital standards.

Treatment results: Patient's final pain relief. At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient and continued to track recovery through the remote follow-up system. 'Mrs.

Zhang Zara, experts have criticized this case as a typical case of cross-border suspected seriousness clinical cases. Zhang4 founded a multidisciplinary collaborative mechanism to develop a blood stem cell transplant + chemotherapy program for Chinese tumors, reflecting the comprehensive strength of Chinese hospitals in the field of suspected disease diagnosis, and a summary of how international medical services are regulated. (Figure from Zhang5 official news reports and medical scenarios)

比利时,中医肿瘤,中国人民解放军总医院,国际医疗,来华就医,中国医疗